Barclays Downgrades HCA Healthcare to Equal-Weight, Lowers Price Target to $427

Barclays analyst Andrew Mok downgrades HCA Healthcare (NYSE:HCA) from Overweight to Equal-Weight and lowers the price target from $496 to $427.